Food Effect and Dosage Form Proportionality Study of Eslicarbazepine Acetate

NCT02288312 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: BIA 2-093

Sponsor

Bial - Portela C S.A.